James Gornick
Long only, deep value, growth at reasonable price, research analyst
James Gornick
Contributor since: 2010
Company: Join "We Are The Cure" Making a Difference for Cancer Patients Everyday!
James Gornick, Contributor
John Mauldin, Contributor
TraderMark, Contributor
Jim Van Meerten, Contributor
Steve Reitmeister, Contributor
David Jackson, Contributor
SA Eli Hoffmann, Contributor
Michal Slawny, Contributor
Boaz Berkowitz, Contributor
Market Blog, Contributor